Truscreen tech success in Chinese cancer trials

Truscreen tech success in Chinese cancer trials
Staff reporters
Truscreen Group has announced its cervical cancer screening technology has produced encouraging results in the second phase of preliminary trials in Sichuan Province, China.Truscreen’s medical device picks up electrical and optical signals to deliver fast results that don't require samples to be sent away for testing.It said 1,243 patients across 14 hospitals were screened for pre-cancerous and cancerous cervical cells, tests the company said produced better or level results with other methods called Human Papillomavirus DNA Test and...